rs104894072
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PP3_ModeratePP5_Very_Strong
The NM_000498.3(CYP11B2):āc.594A>Cā(p.Glu198Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,613,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_000498.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP11B2 | NM_000498.3 | c.594A>C | p.Glu198Asp | missense_variant, splice_region_variant | 3/9 | ENST00000323110.2 | NP_000489.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP11B2 | ENST00000323110.2 | c.594A>C | p.Glu198Asp | missense_variant, splice_region_variant | 3/9 | 1 | NM_000498.3 | ENSP00000325822.2 | ||
GML | ENST00000522728.5 | c.264+1002T>G | intron_variant | 3 | ENSP00000430799.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152032Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000721 AC: 18AN: 249724Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135118
GnomAD4 exome AF: 0.0000855 AC: 125AN: 1461606Hom.: 0 Cov.: 54 AF XY: 0.0000867 AC XY: 63AN XY: 727058
GnomAD4 genome AF: 0.000105 AC: 16AN: 152032Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74270
ClinVar
Submissions by phenotype
Corticosterone 18-monooxygenase deficiency Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Corticosterone 18-monooxygenase deficiency;C3463917:Corticosterone methyloxidase type 2 deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 30, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 198 of the CYP11B2 protein (p.Glu198Asp). This variant is present in population databases (rs104894072, gnomAD 0.01%). This missense change has been observed in individual(s) with aldosterone synthase deficiency (PMID: 9814506, 10965212, 22465514, 30864636). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 242702). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CYP11B2 function (PMID: 9814506, 21237269). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at